Amicus Therapeutics Inc (NASDAQ: FOLD) is -35.24% lower on its value in year-to-date trading and has touched a low of $5.81 and a high of $12.65 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FOLD stock was last observed hovering at around $6.26 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $6.10, the stock is -1.30% and -10.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.52 million and changing -2.56% at the moment leaves the stock -34.84% off its SMA200. FOLD registered -37.76% loss for a year compared to 6-month loss of -38.88%. The firm has a 50-day simple moving average (SMA 50) of $6.844 and a 200-day simple moving average (SMA200) of $9.3619.
The stock witnessed a -6.58% gain in the last 1 month and extending the period to 3 months gives it a -33.33%, and is 0.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.30% over the week and 2.77% over the month.
Amicus Therapeutics Inc (FOLD) has around 499 employees, a market worth around $1.88B and $543.14M in sales. Fwd P/E is 23.62. Profit margin for the company is -5.41%. Distance from 52-week low is 4.99% and -51.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-4.67%).
The EPS is expected to grow by 51.94% this year
380.0 institutions hold shares in Amicus Therapeutics Inc (FOLD), with institutional investors hold 103.54% of the company’s shares. The shares outstanding are 307.92M, and float is at 297.28M with Short Float at 6.79%. Institutions hold 102.82% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 28.59 million shares valued at $$283.6 million. The investor’s holdings represent 9.4111 of the FOLD Shares outstanding. As of 2024-06-30, the second largest holder is PERCEPTIVE ADVISORS LLC with 28.06 million shares valued at $$278.33 million to account for 9.2363 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 27.4 million shares representing 9.0199 and valued at over $$271.81 million, while BLACKROCK INC. holds 8.023 of the shares totaling 24.37 million with a market value of $$241.77 million.
Amicus Therapeutics Inc (FOLD) Insider Activity
The most recent transaction is an insider sale by Campbell Bradley L, the company’s President and CEO. SEC filings show that Campbell Bradley L sold 400 shares of the company’s common stock on Feb 19 ’25 at a price of $10.00 per share for a total of $4000.0. Following the sale, the insider now owns 1.15 million shares.
Still, SEC filings show that on Dec 02 ’24, Campbell Bradley L (President and CEO) disposed off 7,500 shares at an average price of $10.02 for $75124.0. The insider now directly holds 886,654 shares of Amicus Therapeutics Inc (FOLD).
